U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 5

1.
Fig. 1

Fig. 1. From: Depurinating naphthalene–DNA adducts in mouse skin related to cancer initiation.

Pathways of naphthalene metabolism.

Muhammad Saeed, et al. Free Radic Biol Med. ;47(7):1075-1081.
2.
Fig. 5

Fig. 5. From: Depurinating naphthalene–DNA adducts in mouse skin related to cancer initiation.

Comparable mechanisms of cancer initiation by natural estrogens and naphthalene.

Muhammad Saeed, et al. Free Radic Biol Med. ;47(7):1075-1081.
3.
Fig. 2

Fig. 2. From: Depurinating naphthalene–DNA adducts in mouse skin related to cancer initiation.

Formation of depurinating adducts in mouse skin treated with naphthalene or one of its metabolites. The values are the average of two determinations that differed by <20%.

Muhammad Saeed, et al. Free Radic Biol Med. ;47(7):1075-1081.
4.
Fig. 4

Fig. 4. From: Depurinating naphthalene–DNA adducts in mouse skin related to cancer initiation.

Quantitative comparison of depurinating and stable adducts formed in mouse skin treated with naphthalene (500 or 1200 nmol) or one of its metabolites (500 nmol). The values are an average of two determinations that differed by <20%.

Muhammad Saeed, et al. Free Radic Biol Med. ;47(7):1075-1081.
5.
Fig. 3

Fig. 3. From: Depurinating naphthalene–DNA adducts in mouse skin related to cancer initiation.

PAGE analysis of 32P-postlabeled stable DNA adducts obtained from naphthalene and its metabolites in vitro and in vivo. For the in vivo study, naphthalene (1200 or 500 nmol) or its metabolite (500 nmol) was delivered in 50 μl acetone to mouse skin.

Muhammad Saeed, et al. Free Radic Biol Med. ;47(7):1075-1081.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center